The University of New South Wales-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:The University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014233
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The University of New South Wales (UNSW Australia) is an academic university that offer research and education services. The university’s educational services include fine arts education, design, media arts, art and design, art history, theory and art administration, social sciences, engineering, built environment, arts and media, humanities, languages, finance, accounting, banking, taxation, and business law education services. Its engineering education services comprise mechanical, manufacturing, biomedical engineering, chemical, civil, telecommunications, environmental, computer science, electrical, mining, petroleum, photovoltaic, and renewable energy education engineering services. UNSW Australia’ research services include graduate research, medicinal research, postgraduate research, and optometry and vision science research, and others. The university serves students, researchers, and professionals. UNSW Australia is headquartered in Kensington, New South Wales, Australia.

The University of New South Wales – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The University of New South Wales, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The University of New South Wales, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The University of New South Wales, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The University of New South Wales, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The University of New South Wales, Medical Devices Deals, 2011 to YTD 2017 9
The University of New South Wales, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The University of New South Wales, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Noxopharm Enters into Research Agreement with University of New South Wales 11
Gabather Enters into Research Agreement with UNSW 12
Licensing Agreements 13
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 13
The University of New South Wales – Key Competitors 14
The University of New South Wales – Key Employees 15
The University of New South Wales – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 09, 2017: New gene therapy developed with UNSW researchers targets brain disorders 17
Jul 17, 2017: Genome therapy could lead to new treatment for life-threatening blood disorders 18
Aug 23, 2016: Medical scientists discover potent method for improving drug-free fertility treatment 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
The University of New South Wales, Pharmaceuticals & Healthcare, Key Facts, 2015 2
The University of New South Wales, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The University of New South Wales, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The University of New South Wales, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The University of New South Wales, Deals By Therapy Area, 2011 to YTD 2017 8
The University of New South Wales, Medical Devices Deals, 2011 to YTD 2017 9
The University of New South Wales, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Noxopharm Enters into Research Agreement with University of New South Wales 11
Gabather Enters into Research Agreement with UNSW 12
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 13
The University of New South Wales, Key Competitors 14
The University of New South Wales, Key Employees 15
The University of New South Wales, Other Locations 16
The University of New South Wales, Subsidiaries 16

★海外企業調査レポート[The University of New South Wales-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Can-Fite BioPharma Ltd (CANF):製薬・医療:M&Aディール及び事業提携情報
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi pro …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務分析
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Doosan Corporation:企業の戦略・SWOT・財務情報
    Doosan Corporation - Strategy, SWOT and Corporate Finance Report Summary Doosan Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cotinga Pharmaceuticals Inc (COT):製薬・医療:M&Aディール及び事業提携情報
    Summary Cotinga Pharmaceuticals Inc (Cotinga), formerly Critical Outcome Technologies Inc, is a developer of targeted therapeutics with focus on oncology. The company offers pipeline products such as COTI-2 targeting p53 and COTI-259 targeting KRAS. Its research includes program, indication, screeni …
  • Luxshare Precision Industry Co., Ltd. (002475):企業の財務・戦略的SWOT分析
    Luxshare Precision Industry Co., Ltd. (002475) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • OTP Bank Nyrt:企業の戦略・SWOT・財務分析
    OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report Summary OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It offers Inovalon ONE platform and provides data dri …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sturm, Ruger & Company, Inc.:戦略・SWOT・企業財務分析
    Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Jungheinrich AG:企業の戦略・SWOT・財務情報
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mears Group PLC (MER):企業の財務・戦略的SWOT分析
    Summary Mears Group PLC (Mears) is a housing and social care provider. The company offers repairs, rapid response and planned maintenance services for a portfolio of social homes. It provides housing services such as new homes, energy services, housing management, home improvement, branches, planned …
  • NU-Oil and Gas Plc (NUOG):企業の財務・戦略的SWOT分析
    Summary NU-Oil and Gas Plc (NU-Oil), formerly Enegi Oil Plc, is an independent oil and gas company that offers oil and gas exploration and production services. The company offers services such as exploration and development of natural gas, crude oil, and petroleum properties. It concentrates on acqu …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Becker Avionics, Inc.:企業の戦略・SWOT・財務情報
    Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rubicon Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • Miragen Therapeutics Inc (MGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), …
  • CooperVision Inc:企業の製品パイプライン分析2018
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vienna Insurance Group AG:企業の戦略・SWOT・財務情報
    Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report Summary Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆